Filter by content type
Filter by year
Vaccinex, Inc. to Present Data on Its Anti-SEMA4D Compound at the American Association for Cancer Research Annual Meeting 2019
March 6, 2019 - … of the posters are below: Title: “Interim results from CLASSICAL-Lung, a Phase Ib/II study of VX15/2503 (pepinemab) in … of the posters are below: Title: “Interim results from CLASSICAL-Lung, a Phase Ib/II study of VX15/2503 (pepinemab) …
Vaccinex, Inc. to Provide Clinical Data on Posters Presented at the 2019 Annual Meeting of the American Association for Cancer Research (AACR)
April 1, 2019 - … : Title: “Interim results from CLASSICAL-Lung, a Phase Ib/II study of VX15/2503 (pepinemab) in … : Title: “Interim results from CLASSICAL-Lung, a Phase Ib/II study of VX15/2503 (pepinemab) …
Vaccinex Announces Award Notice from the Alzheimer’s Association 2020 Part the Cloud Program
November 14, 2019 - … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. Vaccinex is based in … our plans, expectations and objectives with respect to the CLASSICAL-Lung clinical trial, the combination of pepinemab … our plans, expectations and objectives with respect to the CLASSICAL-Lung clinical trial, the combination of pepinemab …
Vaccinex to Present at the Ladenburg Thalmann 2019 Healthcare Conference
September 24, 2019 - … inhibitor, BAVENCIO® (avelumab), in non-small cell lung cancer (NSCLC) as well as the continuing progress of … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. Vaccinex is based in … inhibitor, BAVENCIO® (avelumab), in non-small cell lung cancer (NSCLC) as well as the continuing progress of …
Vaccinex Announces $3 Million Award from the Alzheimer’s Drug Discovery Foundation
December 10, 2019 - … and our collaboration with Merck KGaA in Non-Small Cell Lung Cancer could bring important benefits to our patients … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. Vaccinex is based in … and our collaboration with Merck KGaA in Non-Small Cell Lung Cancer could bring important benefits to our patients …
Vaccinex, Inc. Presented Previously Disclosed Data from Ongoing Phase 1/2 Trial of VX15/2503 (Pepinemab) in Huntington’s Disease (the “SIGNAL Trial”) at Cambridge Healthtech Institute’s 18th Annual PepTalk
January 17, 2019 - … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. Vaccinex is based … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. Vaccinex is based … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. Vaccinex is based …
Vaccinex, Inc. Announces Completion of Enrollment for Its “SIGNAL” Huntington’s Disease Trial
January 16, 2019 - … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. Vaccinex is based in … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. Vaccinex is based in … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. Vaccinex is based in …
Vaccinex Announces $13.8 Million Private Placement
July 31, 2019 - … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. Vaccinex is based in … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. Vaccinex is based in … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. Vaccinex is based in …
Vaccinex Details Scientific Rationale for Expanding Pepinemab Clinical Programs to Include Alzheimer’s Disease
December 9, 2019 - … with currently active clinical trials in non-small cell lung cancer and Huntington’s disease. Vaccinex is based in … with currently active clinical trials in non-small cell lung cancer and Huntington’s disease. Vaccinex is based in … with currently active clinical trials in non-small cell lung cancer and Huntington’s disease. Vaccinex is based in …
Pagination
- Previous page
- Page 2